This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ivins, J. C.
Right arrow Articles by Dahlin, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ivins, J. C.
Right arrow Articles by Dahlin, D. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
Journal of Bone and Joint Surgery, 1953;35:835-866.
© 1953 by The Journal of Bone and Joint Surgery, Inc

RETICULUM-CELL SARCOMA OF BONE

John C. Ivins M.D.1 and David C. Dahlin M.D.2

1 Section of Orthopaedic Surgery, Mayo Clinic
2 Division of Surgical Pathology, Mayo Clinic

In a survey of 2,000 specimens of primary tumor of bone, forty-nine were found to be reticulum-cell sarcomata. The survey reinforced our conception that reticulum-cell sarcoma is a firmly established entity. It is important to establish the diagnosis by adequate biopsy. Unlike most other primary malignant conditions of bone, reticulum-cell sarcoma appears to be radiosensitive and, in one case in which the tumor disappeared, administration of Coley's toxins was the only treatment. At present, it appears that the prognosis in cases of reticulum-cell sarcoma of bone is significantly better than that in most other primary malignant tumors of bone.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?